The epigenetic modifier PBRM1 restricts the basal activity of the innate immune system by repressing retinoic acid‐inducible gene‐I‐like receptor signalling and is a potential prognostic biomarker for colon cancer
Xing‐sheng Shu; Yingying Zhao; Yanmei Sun; Lan Zhong; Yingduan Cheng; Yixiang Zhang; Kaile Ning; Qian Tao; Yejun Wang; Ying Ying
Author Information: School of Medicine, Health Science Centre
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.